High AST and ALT Levels: What Life Insurance Means for You

How High AST and ALT Impact Life Insurance

AST (aspartate transaminase) and ALT (alanine transaminase) are liver enzymes measured in blood tests. Elevated levels typically signal liver inflammation or damage, prompting insurers to view applicants as higher medical risk. When underwriting, carriers may request additional documentation, impose higher premiums, or deny coverage if levels remain chronically high. The degree of impact depends on the magnitude of elevation, trend over time, and the presence of underlying conditions such as hepatitis, fatty liver disease, or alcohol misuse.

Typical Underwriting Thresholds and Variability

Insurers set their own thresholds, but many use the following reference ranges:

• AST: 10–40 U/L
• ALT: 7–56 U/L

For values exceeding these limits, an insurer may consider a "medical review." The higher the value—especially above 200 U/L— the greater the likelihood of a medical policy review and potential premium increase.

Factors That Influence Underwriting Decisions

Insurers evaluate several variables beyond raw numbers:

• Trend: A single elevated reading that later normalizes is less concerning than a persistent rise.
• Age and Sex: Women and younger applicants may receive more lenient thresholds.
• Co‑existing Conditions: Chronic liver disease, alcohol use disorder, or metabolic syndrome amplify risk.
• Lifestyle Changes: Weight loss, reduced alcohol intake, or new medications can improve future underwriting prospects.

Strategies to Improve Eligibility and Premiums

1. Get a Full Workup: A comprehensive liver panel, viral hepatitis screening, and imaging (ultrasound or FibroScan) can confirm or rule out serious disease.

2. Reduce Alcohol Consumption: Cutting or eliminating alcohol can lower AST/ALT within weeks.

3. Address Metabolic Factors: Weight loss, exercise, and a balanced diet reduce fatty liver and enzyme levels.

4. Document Improvements: Provide insurers with updated lab results showing trends toward normal values.

5. Shop Around: Some specialty insurers focus on "high‑risk" applicants and offer competitive rates if the underlying cause is well documented.

Specialty Insurance Options for Elevated Enzymes

Traditional life insurers may deny or surcharge high‑AST/ALT applicants. Specialty carriers, however, offer:

• "Medical‑condition‑specific" policies that cover individuals with chronic liver disease.
• "Underwriting flexibility" plans that accept higher enzymes in exchange for higher premiums or reduced coverage amounts.

These policies often require a detailed medical history, recent labs, and sometimes a physician's endorsement.

When to Seek Professional Advice

If your AST or ALT levels are consistently above normal and you face coverage challenges, consult a gastroenterologist for a thorough assessment. A specialist can provide a formal diagnosis, recommend treatment, and supply documentation that may ease underwriting.

Key Takeaways

Elevated AST and ALT signal increased risk for life insurers, leading to higher premiums or denial. Trends, underlying causes, and lifestyle factors significantly influence underwriting. By addressing liver health proactively, documenting improvements, and exploring specialty insurers, applicants can secure coverage and potentially lower costs.